Drug research

BCX7353 capsules

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Berotralstat

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in JapanNCT03873116	BioCryst Pharmaceuticals	Phase 3	Completed	2021-07-08Actual
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAENCT03485911	BioCryst Pharmaceuticals	Phase 3	Completed	2019-04-10Actual

BioCryst PharmaceuticalsCompletedPrimary completion: 2021-07-08 · Actual

Trial details

BioCryst PharmaceuticalsCompletedPrimary completion: 2019-04-10 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.